Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
231901-2021 - Belgium-Brussels: Production, Priority-purchasing Options and Supply of Covid-19 Vaccines, Including Adapted Vaccines to SARS-CoV-2 Variants and Paediatric Formulations of such Vaccines for EU Member States
Belgium-Brussels: Feasibility Study of an Active-substance-based Review System (‘Monographs’) and Other Potential Alternatives for the Environmental Risk Assessment of Veterinary Medicinal Products
Section I: Contracting authority
Section II: Object
Feasibility Study of an Active-substance-based Review System (‘Monographs’) and Other Potential Alternatives for the Environmental Risk Assessment of Veterinary Medicinal Products
The study aims to identify, collect and analyse evidence to assess the feasibility of the active substance based approach and of possible alternatives, against the reference of the current product-based approach for ERA in the Veterinary Medicinal Products. Quantitative and qualitative data to assess the feasibility of the options and identify the expected impacts shall be provided and analysed in line with the quality standards and the principles established in the European Commission's Better Regulation Guidelines and Toolbox. The study will be based on the VMP Regulation and will focus on the main pillars of that legislation.
Belliard 232, White Park (B232), rue Breydel 2-10,B-1040 Brussels, BEL.
Procurement of a feasibility study of an active-substance-based review system (‘Monographs’) and other potential alternatives for the Environmental Risk Assessment of Veterinary Medicinal Products.
See internet address provided in Section I.3).
Section III: Legal, economic, financial and technical information
Section IV: Procedure
Section VI: Complementary information